Alterity Therapeutics (ATHE) Financial Ratios

For fiscal 2026 (fiscal year ended Jun 30, 2026), Alterity Therapeutics had return on equity of -55.0% (down from -43.2%), debt-to-equity of 0.01 (up from 0.00), a current ratio of 14.52 (up from 12.98) and return on assets of -34.1% (down from -28.1%). A current ratio of 14.52 means current assets exceed current liabilities.

Alterity Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Jun 2026	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Valuation Ratios
P/S Ratio	34.65	16.78	5.22	4.36	6.11	0.27
P/B Ratio	2.93	2.15	1.52	0.75	0.88	0.04
Price/Tangible Book	2.93	2.15	1.52	0.75	0.88	-
Enterprise Value Ratios
EV/Revenue	21.04	15.97	2.22	-	-	-5.99
EV/EBITDA	-	-	-	-	-	1.78
EV/EBIT	-	-	-	-	-	1.77
EV/FCF	-	-	-	-	-	1.55
Profitability & Returns
Return on Equity (ROE)	-54.98%	-43.23%	-104.47%	-47.38%	-38.97%	-81.39%
Return on Assets (ROA)	-34.08%	-28.09%	-52.66%	-26.64%	-25.85%	-69.73%
Return on Invested Capital (ROIC)	-	-	-	-	-	-7428.82%
Return on Capital Employed (ROCE)	-58.50%	-34.50%	-141.60%	-63.80%	-43.60%	-80.42%
Leverage & Solvency Ratios
Debt/Equity	0.01	0.00	0.01	0.01	0.00	0.00
Liquidity Ratios
Current Ratio	14.52	12.98	3.54	6.17	7.07	10.92
Quick Ratio	14.26	12.62	3.10	5.58	6.79	10.56
Efficiency Ratios
Asset Turnover	0.08	0.17	0.17	0.11	0.14	0.21
Yield & Distribution Ratios
Earnings Yield	-18.71%	-13.31%	-91.15%	-80.84%	-41.06%	-
FCF Yield	-18.01%	-12.55%	-60.11%	-117.35%	-39.71%	-
Buyback Yield	-64.53%	-75.31%	-50.29%	-0.91%	-41.79%	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Alterity Therapeutics Financial Ratios

What is Alterity Therapeutics's return on equity?

Alterity Therapeutics's return on equity (ROE) was -55.0% for fiscal 2026 (period ended Jun 30, 2026). It was -43.2% a year earlier.

What is Alterity Therapeutics's debt-to-equity ratio?

Alterity Therapeutics's debt-to-equity ratio was 0.01 for fiscal 2026 (period ended Jun 30, 2026). It was 0.00 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition